News
Net Revenue of $38.9 million Delivered record Q1 2025 Adjusted EBITDA of $6.2 million Reached settlement with Mylan Pharmaceuticals, Inc., regarding ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback